Physician profile
Robert Jacobson
NPI 1205915378
$125,101.90
in general payments reported to CMS, 2019-2025
29 companies · $24K in 2025
The $24K reported for 2025 was more than what 96% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,486 · 2020: $5,917 · 2021: $8,716 · 2022: $24K · 2023: $54K · 2024: $6,513 · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $66K · Travel and Lodging: $11K · Consulting Fee: $5,417 · Food and Beverage: $1,741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $66,208.47 |
| Travel and Lodging | $11,227.10 |
| Consulting Fee | $5,416.50 |
| Food and Beverage | $1,740.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $121,912.85 | 2019-2025 | Gattex |
| Abbvie INC. | $810.31 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $625.66 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $275.54 | 2019-2021 | |
| Braintree Laboratories, INC. | $230.54 | 2019-2021 | |
| Shire North American Group INC | $186.45 | 2019 | |
| Thd America, INC. | $158.83 | 2021 | |
| Mallinckrodt Enterprises LLC | $133.44 | 2019 | |
| Ethicon US, LLC | $104.35 | 2019-2021 | |
| Tetraphase Pharmaceuticals, INC. | $90.54 | 2019 | |
| Axonics, INC. | $63.88 | 2020-2021 | |
| Davol INC. | $58.24 | 2019 | |
| Allergan, INC. | $51.35 | 2020 | |
| Ferring Pharmaceuticals INC. | $48.48 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $44.72 | 2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $41.35 | 2021 | |
| Acell, INC. | $39.06 | 2019-2020 | |
| Medtronic USA, INC. | $38.75 | 2020 | |
| Pfizer INC. | $34.70 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $25.45 | 2024 | Xarelto |
| Innovation Technologies INC | $16.29 | 2021 | |
| W. L. Gore & Associates, INC. | $15.18 | 2020 | |
| Acacia Pharma INC | $15.01 | 2021 | |
| Kci USA, INC. | $14.74 | 2020 | |
| Prescient Surgical | $13.87 | 2019 | |
| Qol Medical, LLC | $13.63 | 2019 | |
| Integra Lifesciences Corporation | $13.38 | 2020 | |
| Covidien Lp | $12.86 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Jacobson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.